NCT00553865View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions

Essential Hypertension

Interventions

DRUG

OJP-2028

Experimental: 1mg/day, 2mg/day, 4mg/day for 8 weeks. Placebo Comparator: Placebo.day for 8 weeks. Reference group(Group 5): Reference Drug/day for 8 weeks.

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do